Gemini Therapeutics, Inc.
If you purchased Gemini Therapeutics, Inc. securities and would like to join the action, please click "Join This Action" below.
GMTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF GEMINI THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS
August 10, 2022.
New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Gemini Therapeutics, Inc. (NASDAQ: GMTX) and Disc Medicine, Inc. is fair to Gemini shareholders. Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company.
The investigation concerns whether Gemini and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Gemini shareholders; and (2) disclose all material information necessary for Gemini shareholders to adequately assess and value the merger consideration. On behalf of Gemini shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.